Top

Neurological Research and Practice

Published in:

Open Access 01-12-2021 | SARS-CoV-2 | Review

Neurological manifestations of COVID-19 – an approach to categories of pathology

Authors: Yana Leven, Julian Bösel

Published in: Neurological Research and Practice | Issue 1/2021

Abstract

Background

Various neurological manifestations of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported, associated with a broad spectrum of diverse neurological symptoms and syndromes. Estimating rate and relevance of these manifestations remains difficult as there is a lack of standardised case definitions.

Methods

We defined comprehensive categories including most reported neurological manifestations associated with SARS-CoV-2 to allow for a more standardised data collection. After a literature search of MEDLINE with ten keywords, 12 selected studies and larger case series were included. We compared the rate and relevance of neurological manifestations in hospitalized patients. We propose four main categories including 1) cerebrovascular disease, 2) inflammatory syndromes of the central nervous system (CNS), peripheral nervous system (PNS) and muscle, 3) metabolic/toxic dysfunction of CNS, PNS and muscle and 4) miscellaneous disorders.

Conclusion

Ageusia (702) and anosmia (805) have been reported as the most common and the first occurring neurological symptoms. Cerebrovascular disease (451) and encephalopathy (663) were associated with a more severe course and worse clinical outcome. Any neurological manifestation was associated with a longer hospital stay and a higher morbidity and mortality compared to patients without neurological manifestations. We suggest reporting future neurological manifestations of coronavirus disease-19 (COVID-19) following a pathophysiology-based approach using standardized pre-defined case definitions to yield more specific and comparable data.

Andalib, S., Biller, J., Di Napoli, M., Moghimi, N., McCullough, L. D., Rubinos, C. A., … Divani, A. A. (2021). Peripheral nervous system manifestations associated with COVID-19. Current Neurology and Neuroscience Reports, 21(3), 9. https://doi.org/10.1007/s11910-021-01102-5.CrossRefPubMedPubMedCentral

Association, A. P (2013). Diagnostic and statistical manual of mental disorders. https://doi.org/10.1176/appi.books.9780890425596.CrossRef

Ellul, M. A., Benjamin, L., Singh, B., Lant, S., Michael, B. D., Easton, A., … Solomon, T. (2020). Neurological associations of COVID-19. Lancet Neurology, 19(9), 767–783. https://doi.org/10.1016/S1474-4422(20)30221-0.CrossRefPubMed

Ermis, U., Rust, M. I., Bungenberg, J. et al (2021). Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients.. Neurol Res Pract, 3(17), 10. https://doi.org/10.1186/s42466-021-00116-1.

Fan, S., Xiao, M., Han, F., Xia, P., Bai, X., Chen, H., … Guan, H. (2020). Neurological manifestations in critically ill patients With COVID-19: A retrospective study. Frontiers in Neurology, 11, 806. https://doi.org/10.3389/fneur.2020.00806.CrossRefPubMedPubMedCentral

Fotuhi, M., Mian, A., Meysami, S., & Raji, C. A. (2020). Neurobiology of COVID-19. Journal of Alzheimer's Disease, 76(1), 3–19. https://doi.org/10.3233/JAD-200581.CrossRefPubMed

Frontera, J., Mainali, S., Fink, E. L., Robertson, C. L., Schober, M., Ziai, W., … Study, G.-N (2020a). Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study design and rationale. Neurocritical Care, 33(1), 25–34. https://doi.org/10.1007/s12028-020-00995-3.CrossRefPubMed

Frontera, J. A., Sabadia, S., Lalchan, R., Fang, T., Flusty, B., Millar-Vernetti, P., … Galetta, S. (2020b). A prospective study of neurologic disorders in hospitalized COVID-19 patients in New York City. Neurology., 96(4), e575–e586. https://doi.org/10.1212/WNL.0000000000010979.CrossRefPubMed

Good, D. C. (1990). Chapter 55 cerebrovascular disease. In Butterworths (Ed.), Clinical methods: the history, physical and laboratory examinations, (3rd ed., ).

10.

Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., … Dalmau, J. (2016). A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurology, 15(4), 391–404. https://doi.org/10.1016/S1474-4422(15)00401-9.CrossRefPubMed

11.

Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., … Meziani, F. (2020). Neurologic features in severe SARS-CoV-2 infection. The New England Journal of Medicine, 382(23), 2268–2270. https://doi.org/10.1056/NEJMc2008597.CrossRefPubMed

12.

Jakob, C. E. M., Borgmann, S., Duygu, F., Behrends, U., Hower, M., Merle, U., … Vehreschild, J. J. (2021). First results of the “lean European open survey on SARS-CoV-2-infected patients (LEOSS)”. Infection, 49(1), 63–73. https://doi.org/10.1007/s15010-020-01499-0.CrossRefPubMed

13.

Kim, J. W., Abdullayev, N., Neuneier, J. et al (2021). Post-COVID-19 encephalomyelitis. Neurological Research and Practice, 3(18), 2.https://doi.org/10.1186/s42466-021-00113-4.

14.

Koh, J. S., De Silva, D. A., Quek, A. M. L., Chiew, H. J., Tu, T. M., Seet, C. Y. H., … Umapathi, T. (2020). Neurology of COVID-19 in Singapore. Journal of the Neurological Sciences, 418, 117118. https://doi.org/10.1016/j.jns.2020.117118.CrossRefPubMedPubMedCentral

15.

Liotta, E. M., Batra, A., Clark, J. R., Shlobin, N. A., Hoffman, S. C., Orban, Z. S., & Koralnik, I. J. (2020). Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Annals of Clinical Translational Neurology, 7(11), 2221–2230. https://doi.org/10.1002/acn3.51210.CrossRefPubMedPubMedCentral

16.

Mao, L., Jin, H., Wang, M., Hu Y, Chen S, He Q, …, Miao X.(2020). Neurological manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan China

17.

Matschke, J., Lütgehetmann, M., Hagel, C., Sperhake, J. P., Schröder, A. S., Edler, C., … Glatzel, M. (2020). Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurology, 19(11), 919–929. https://doi.org/10.1016/S1474-4422(20)30308-2.CrossRefPubMed

18.

McGonagle, D., Sharif, K., O'Regan, A., & Bridgewood, C. (2020). The role of cytokines including Interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmunity Reviews, 19(6), 102537. https://doi.org/10.1016/j.autrev.2020.102537.CrossRefPubMedPubMedCentral

19.

Meppiel, E., Pfeiffer-Smadja, N., & Maury, A. (2020). Neurological manifestations associated with Covid-19: a multicentre registry. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(20)30698-4/fulltext

20.

Panciani, P. P., Saraceno, G., Zanin, L., Renisi, G., Signorini, L., Battaglia, L., & Fontanella, M. M. (2020). SARS-CoV-2: “three-steps” infection model and CSF diagnostic implication. Brain, Behavior, and Immunity, 87, 128–129. https://doi.org/10.1016/j.bbi.2020.05.002.CrossRefPubMedPubMedCentral

21.

Paterson, R. W., Brown, R. L., Benjamin, L., Nortley, R., Wiethoff, S., Bharucha, T., … Zandi, M. S. (2020). The emerging spectrum of COVID-19 neurology: Clinical, radiological and laboratory findings. Brain, 143(10), 3104–3120. https://doi.org/10.1093/brain/awaa240.CrossRefPubMedPubMedCentral

22.

Porta-Etessam, J., Núñez-Gil, I. J., González García, N., Fernandez-Perez, C., Viana-Llamas, M. C., Eid, C. M., … Estrada, V. (2021). COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry. Infection. https://doi.org/10.1007/s15010-021-01587-9.

23.

Rifino, N., Censori, B., Agazzi, E., Alimonti, D., Bonito, V., Camera, G., … Sessa, M. (2020). Neurologic manifestations in 1760 COVID-19 patients admitted to Papa Giovanni XXIII hospital, Bergamo, Italy. Journal of Neurology. https://doi.org/10.1007/s00415-020-10251-5.

24.

Romero-Sánchez, C. M., Díaz-Maroto, I., Fernández-Díaz, E., Sánchez-Larsen, Á., Layos-Romero, A., García-García, J., … Segura, T. (2020). Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology, 95(8), e1060–e1070. https://doi.org/10.1212/WNL.0000000000009937.CrossRefPubMed

25.

Scott, T. F., Frohman, E. M., De Seze, J., Gronseth, G. S., Weinshenker, B. G., & Neurology, T. a. T. A. S. o. A. A. o (2011). Evidence-based guideline: Clinical evaluation and treatment of transverse myelitis: Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology, 77(24), 2128–2134. https://doi.org/10.1212/WNL.0b013e31823dc535.CrossRefPubMed

26.

Sepehrinezhad, A., Shahbazi, A., & Negah, S. S. (2020). COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review. Journal of Neurovirology, 26(3), 324–329. https://doi.org/10.1007/s13365-020-00851-2.CrossRefPubMed

27.

Slooter, A. J. C., Otte, W. M., Devlin, J. W., Arora, R. C., Bleck, T. P., Claassen, J., … Stevens, R. D. (2020). Updated nomenclature of delirium and acute encephalopathy: Statement of ten societies. Intensive Care Medicine, 46(5), 1020–1022. https://doi.org/10.1007/s00134-019-05907-4.CrossRefPubMedPubMedCentral

28.

Solomon, T., Michael, B. D., Smith, P. E., Sanderson, F., Davies, N. W., Hart, I. J., … Groups, N. E. G. D. a. S. (2012). Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines. The Journal of Infection, 64(4), 347–373. https://doi.org/10.1016/j.jinf.2011.11.014.CrossRefPubMed

29.

Tunkel, A. R., Glaser, C. A., Bloch, K. C., Sejvar, J. J., Marra, C. M., Roos, K. L., … America, I. D. S. o. (2008). The management of encephalitis: Clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases, 47(3), 303–327. https://doi.org/10.1086/589747.CrossRefPubMed

30.

Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J. (2004). Practice guidelines for the management of bacterial meningitis. Clinical Infectious Diseases, 39(9), 1267–1284. https://doi.org/10.1086/425368.CrossRefPubMed

31.

Tunkel, A. R., Hasbun, R., Bhimraj, A., Byers, K., Kaplan, S. L., Scheld, W. M., … Zunt, J. R. (2017). 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated Ventriculitis and meningitis. Clinical Infectious Diseases, 64(6), e34–e65. https://doi.org/10.1093/cid/ciw861.CrossRefPubMedPubMedCentral

32.

Uversky, V. N., Elrashdy, F., Aljadawi, A., Ali, S. M., Khan, R. H., & Redwan, E. M. (2021). Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How? Journal of Neuroscience Research, 99(3), 750–777. https://doi.org/10.1002/jnr.24752.CrossRefPubMed

33.

Varatharaj, A., Thomas, N., Ellul, M. A., Davies, N. W. S., Pollak, T. A., Tenorio, E. L., … Group, C. S (2020). Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry, 7(10), 875–882. https://doi.org/10.1016/S2215-0366(20)30287-X.CrossRefPubMedPubMedCentral

34.

Venkatesan, A., Tunkel, A. R., Bloch, K. C., Lauring, A. S., Sejvar, J., Bitnun, A., … Consortium, I. E. (2013). Case definitions, diagnostic algorithms, and priorities in encephalitis: Consensus statement of the international encephalitis consortium. Clinical Infectious Diseases, 57(8), 1114–1128. https://doi.org/10.1093/cid/cit458.CrossRefPubMedPubMedCentral

35.

WHO. (2020a). WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2D-11-march-2020

36.

WHO. (2020b ). Coronavirus disease 2019 (COVID-19) Situation Report – 61. https://apps.who.int/iris/bitstream/handle/10665/331605/nCoVsitrep21Mar2020-eng.pdf?sequence=1&isAllowed=y

37.

Zubair, A. S., McAlpine, L. S., Gardin, T., Farhadian, S., Kuruvilla, D. E., & Spudich, S. (2020). Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: A review. JAMA Neurology, 77(8), 1018–1027. https://doi.org/10.1001/jamaneurol.2020.2065.CrossRefPubMedPubMedCentral

Title: Neurological manifestations of COVID-19 – an approach to categories of pathology
Authors: Yana Leven
Julian Bösel
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: SARS-CoV-2
COVID-19
Encephalitis
Encephalopathy
Published in: Neurological Research and Practice / Issue 1/2021
Electronic ISSN: 2524-3489
DOI: https://doi.org/10.1186/s42466-021-00138-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Neurological manifestations of COVID-19 – an approach to categories of pathology

Abstract

Background

Methods

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2021

Prognostication after intracerebral hemorrhage: a review

Development and reliability of the histological THROMBEX-classification rule for thrombotic emboli of acute ischemic stroke patients

Stopping “transient ischemic attacks” by antiplatelet withdrawal

Index event of cerebral amyloid angiopathy (CAA) determines long-term prognosis and recurrent events (retrospective analysis and clinical follow-up)

N,N-Dimethylglycine in patients with progressive multiple sclerosis: result of a pilot double-blind, placebo, controlled randomized clinical trial

Optic disc drusen mimicking Idiopathic Intracranial Hypertension (IIH): rely on ultrasound